Drugs / ALVAC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00212888 | Apr 2004 → Jul 2010 | HIV infectious disease | Ottawa Hospital Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00212888 ↗ |
| Modality | Vaccine | “A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.” PMID 21330911 ↗ Mar 2011 |
| Route | Intramuscular | “ALVAC 1 ml i.m.” NCT00212888 ↗ |